HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide.

Abstract
Qvar Autohaler efficacy on asthma control, assessed with E. Juniper asthma control questionnaire (ACQ), was compared with fluticasone and budesonide. An open randomized study, stratified (2:1) on the intake of long-acting beta2-mimetics (LAbeta2), was performed in patients with moderate to severe poorly controlled asthma (defined by at least one nocturnal discomfort in the last 5 days or a mean of 2 puffs of short-acting beta2-mimetics in the last 7 days or exercise dyspnea) despite treatment with beclomethasone < or = 1000 microg/day (or equivalent). 460 patients received Qvar Autohaler 800 microg/day (n = 149), fluticasone Diskus 1000 microg/day (n = 149) or budesonide Turbuhaler 1600 microg/day (n = 162) during 12 weeks. Asthma control improved in all groups, with no difference between groups. For patients treated with LAbeta2 (n = 286) a significantly greater improvement of the ACQ score was obtained with Qvar Autohaler versus fluticasone (1.0 +/- 1.0 vs. 0.6 +/- 0.9; P = 0.019), but not versus budesonide (0.9 +/- 0.9). Pulmonary function test improvements were similar in the 3 groups. The significant improvement in asthma control in patients receiving LAbeta2 suggests potential advantages for extrafine aerosols as part of anti-inflammatory treatment optimization.
AuthorsMathieu Molimard, Yan Martinat, Yves Rogeaux, Dominique Moyse, Jean-Yves Pello, Violaine Giraud
JournalRespiratory medicine (Respir Med) Vol. 99 Issue 6 Pg. 770-8 (Jun 2005) ISSN: 0954-6111 [Print] England
PMID15878495 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Aerosols
  • Androstadienes
  • Anti-Inflammatory Agents
  • Bronchodilator Agents
  • Ethanolamines
  • Leukotriene Antagonists
  • Budesonide
  • Salmeterol Xinafoate
  • Fluticasone
  • Beclomethasone
  • Albuterol
  • Formoterol Fumarate
Topics
  • Administration, Inhalation
  • Adult
  • Aerosols
  • Albuterol (analogs & derivatives, therapeutic use)
  • Androstadienes (therapeutic use)
  • Anti-Inflammatory Agents (therapeutic use)
  • Asthma (drug therapy, physiopathology)
  • Beclomethasone (administration & dosage, therapeutic use)
  • Bronchodilator Agents (therapeutic use)
  • Budesonide (therapeutic use)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Ethanolamines (therapeutic use)
  • Female
  • Fluticasone
  • Formoterol Fumarate
  • Humans
  • Leukotriene Antagonists (therapeutic use)
  • Male
  • Metered Dose Inhalers
  • Middle Aged
  • Particle Size
  • Peak Expiratory Flow Rate
  • Respiratory Function Tests
  • Salmeterol Xinafoate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: